Bharat Biotech to launch Covaxin in Q2 2021

The company#39;s vaccine candidate -Covaxin- has been developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV) using inactivated Sars-Cov-2, the virus that causes COVID-19. The virus was isolated in an ICMR lab.

from Moneycontrol Business News https://ift.tt/2JsLMIr